Inactivation of the MAL Gene in Breast Cancer Is a Common Event That Predicts Benefit from Adjuvant Chemotherapy

Dysregulation of MAL (myelin and lymphocyte protein) has been implicated in several malignancies including esophageal, ovarian, and cervical cancers. The MAL protein functions in apical transport in polarized epithelial cells; therefore, its disruption may lead to loss of organized polarity characteristic of most solid malignancies. Bisulfite sequencing of the MAL promoter CpG island revealed hypermethylation in breast cancer cell lines and 69% of primary tumors analyzed compared with normal breast epithelial cells. Differential methylation between normal and cancer DNA was confined to the proximal promoter region. In a subset of breast cancer cell lines including T47D and MCF7 cells, promoter methylation correlated with transcriptional silencing that was reversible with the methylation inhibitor 5-aza-2′-deoxycytidine. In addition, expression of MAL reduced motility and resulted in a redistribution of lipid raft components in MCF10A cells. MAL protein expression measured by immunohistochemistry revealed no significant correlation with clinicopathologic features. However, in patients who did not receive adjuvant chemotherapy, reduced MAL expression was a significant predictive factor for disease-free survival. These data implicate MAL as a commonly altered gene in breast cancer with implications for response to chemotherapy. (Mol Cancer Res 2009;7(2):199–209)

[1]  Tetsuo Ito,et al.  A genome-wide search identifies epigenetic silencing of somatostatin, tachykinin-1, and 5 other genes in colon cancer. , 2006, Gastroenterology.

[2]  司履生.  Cancer epigenetics , 2006 .

[3]  P. Elson,et al.  MAL is expressed in a subset of Hodgkin lymphoma and identifies a population of patients with poor prognosis. , 2006, American journal of clinical pathology.

[4]  Susan K. Murphy,et al.  High throughput detection of M6P/IGF2R intronic hypermethylation and LOH in ovarian cancer , 2006, Nucleic acids research.

[5]  O. Olopade,et al.  BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomy. , 2005, Cancer research.

[6]  M. West,et al.  Patterns of Gene Expression That Characterize Long-term Survival in Advanced Stage Serous Ovarian Cancers , 2005, Clinical Cancer Research.

[7]  P. Laird.  Cancer epigenetics. , 2005, Human molecular genetics.

[8]  Paul Cairns,et al.  Tumor Suppressor Gene Promoter Hypermethylation in Serum of Breast Cancer Patients , 2004, Clinical Cancer Research.

[9]  M. Szyf,et al.  DNA demethylation and cancer: therapeutic implications. , 2004, Cancer letters.

[10]  M. Marazuela,et al.  Expression of MAL and MAL2, two elements of the protein machinery for raft-mediated transport, in normal and neoplastic human tissue. , 2004, Histology and histopathology.

[11]  M. Emi,et al.  Down‐regulation of members of glycolipid‐enriched membrane raft gene family, MAL and BENE, in cervical squamous cell cancers , 2004, The journal of obstetrics and gynaecology research.

[12]  Takaaki Masuda,et al.  MAL gene expression in esophageal cancer suppresses motility, invasion and tumorigenicity and enhances apoptosis through the Fas pathway , 2003, Oncogene.

[13]  M. West,et al.  Gene expression predictors of breast cancer outcomes , 2003, The Lancet.

[14]  M. Marazuela,et al.  Expression of MAL, an Integral Protein Component of the Machinery for Raft-mediated Apical Transport, in Human Epithelia , 2003, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[15]  A. Dopazo,et al.  Identification of genes involved in resistance to interferon-alpha in cutaneous T-cell lymphoma. , 2002, The American journal of pathology.

[16]  Peter A. Jones,et al.  The fundamental role of epigenetic events in cancer , 2002, Nature Reviews Genetics.

[17]  W. Sly,et al.  Methylation patterns of the human β-glucuronidase gene locus: Boundaries of methylation and general implications for frequent point mutations at CpG dinucleotides , 2002 .

[18]  P. Arvan,et al.  MAL Mediates Apical Transport of Secretory Proteins in Polarized Epithelial Madin-Darby Canine Kidney Cells* , 2001, The Journal of Biological Chemistry.

[19]  M. A. Alonso,et al.  The role of lipid rafts in signalling and membrane trafficking in T lymphocytes. , 2001, Journal of cell science.

[20]  Christoph Grunau,et al.  Bisulfite genomic sequencing: systematic investigation of critical experimental parameters , 2001, Nucleic Acids Res..

[21]  J. Issa,et al.  Changes in DNA Methylation in Neoplasia: Pathophysiology and Therapeutic Implications , 2001, Annals of Internal Medicine.

[22]  R. Puertollano,et al.  The MAL proteolipid is necessary for the overall apical delivery of membrane proteins in the polarized epithelial Madin-Darby canine kidney and fischer rat thyroid cell lines. , 2000, Molecular biology of the cell.

[23]  K. Simons,et al.  VIP17/MAL, a lipid raft-associated protein, is involved in apical transport in MDCK cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[24]  M. A. Alonso,et al.  MAL, a novel integral membrane protein of human T lymphocytes, associates with glycosylphosphatidylinositol‐anchored proteins and Src‐like tyrosine kinases , 1998, European journal of immunology.

[25]  M. Marazuela,et al.  Expression of the MAL gene in the thyroid: the MAL proteolipid, a component of glycolipid-enriched membranes, is apically distributed in thyroid follicles. , 1998, Endocrinology.

[26]  Stephen B. Baylin,et al.  Mapping Patterns of CpG Island Methylation in Normal and Neoplastic Cells Implicates Both Upstream and Downstream Regions inde Novo Methylation* , 1997, The Journal of Biological Chemistry.

[27]  H. Lodish,et al.  Flotillin and Epidermal Surface Antigen Define a New Family of Caveolae-associated Integral Membrane Proteins* , 1997, The Journal of Biological Chemistry.

[28]  Antonio Tugores,et al.  A tandem array of Sp-1 sites and a reverse initiator element are both required for synergistic transcriptional activation of the T-cell-specific MAL gene. , 1997, DNA and cell biology.

[29]  G. Lozano,et al.  Dominance of wild-type p53-mediated transcriptional activation in breast epithelial cells. , 1996, Oncogene.

[30]  M Murata,et al.  VIP17/MAL, a proteolipid in apical transport vesicles , 1995, FEBS letters.

[31]  Deborah A. Brown,et al.  Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface , 1992, Cell.

[32]  V. Band,et al.  Human papilloma virus DNAs immortalize normal human mammary epithelial cells and reduce their growth factor requirements. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[33]  S. Weissman,et al.  cDNA cloning and sequence of MAL, a hydrophobic protein associated with human T-cell differentiation. , 1987, Proceedings of the National Academy of Sciences of the United States of America.